Search
Close this search box.

TROG Cancer Research will work with clinicians at Townsville Hospital, as well as other national experts, to implement a research program aimed at understanding how to best use new MRI LINAC technology to benefit cancer patients.

Weighing in at 8,000 kilograms, the MRI LINAC is one of the most sophisticated cancer treatment machines in the southern hemisphere.

The high-tech device combines a Magnetic Resonance Imaging (MRI) scanner and a radiotherapy linear accelerator (LINAC) into one integrated system.

The MRI LINAC can monitor the movement of tumor locations caused by normal body movements during treatment. Due to superior imaging the MRI LINAC enables greater accuracy with radiation therapy treatment delivery and reduced damage to surrounding healthy tissue in the body.

The linear accelerator is part of a $10 million package funded by the State and Commonwealth Government, which includes new radiation treatment machines and an upgrade to the existing fleet.

Minister for Health and Minister for Ambulance Services, Steven Miles, inspected the accelerator at the Townsville Cancer Centre and said it was fantastic to see a regional centre leading the way in the provision of Australian-leading cancer treatment.

“This is the most sophisticated and advanced cancer treatment machine in Australia and the southern-hemisphere,” Steven said.

“It is brilliant that the North Queensland community will be the first in Australia to have access to this cutting-edge equipment.

“This machine will make a huge difference to the lives of patients with cancer living in North Queensland.”

In support of this emerging technology, TROG Cancer Research are establishing an MRI in Radiation Therapy Special Interest Group. To express interest in joining this interest group please email TROG@trog.com.au.

Related Post

23 October, 2024

New Cancer Australia grant supports TROG work

23 October 2024: TROG Cancer Research is thrilled to

15 October, 2024

Diversity, equity and inclusion at heart of TROG work

15 October 2024: TROG Cancer Research has made a